Heidi Brumbach

Corporate Officer/Principal at Confirmit AS

Technology Services

Health Technology

Profile

Heidi Brumbach currently works as an Executive Vice President-Global Human Resources at Confirmit AS.
Currently, she holds the position of Vice President-People & Culture at Carmot Therapeutics, Inc.

Heidi Brumbach active positions

Companies	Position	Start
Confirmit AS Confirmit AS Packaged SoftwareTechnology Services Confirmit AS engages in the development og online survey technologies for market research agencies. It offers software to collect customer and employee feedback, as well as market research applications for survey creation, data analysis, and reporting. The company was founded on October 7, 1996 and is headquartered in Oslo, Norway.	Corporate Officer/Principal	-
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA.	Human Resources Officer	31/12/2022

All active positions of Heidi Brumbach

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Heidi Brumbach's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Confirmit AS Confirmit AS Packaged SoftwareTechnology Services Confirmit AS engages in the development og online survey technologies for market research agencies. It offers software to collect customer and employee feedback, as well as market research applications for survey creation, data analysis, and reporting. The company was founded on October 7, 1996 and is headquartered in Oslo, Norway.	Technology Services
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA.	Health Technology